BMRN vs PJT · P/E 40, rev $1.76B vs P/E 30, rev $904.5M
Biomarin Pharmaceutical Inc (BMRN) versus PJT Partners Inc (PJT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
PJT Partners Inc (PJT) is a capital markets company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PJT revenue for 2026-06-30 was $904.5M. Net income was $106.3M. PJT currently screens at market cap $6.72B and trailing P/E 29.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PJT currently screens at market cap $6.72B and trailing P/E 29.6.
Not investment advice. Open the BMRN and PJT stock pages for the full models.
Not investment advice.